{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:22:29Z","timestamp":1740144149318,"version":"3.37.3"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The University of Sydney Thompson Fellowship"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1195460"],"award-info":[{"award-number":["1195460"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s40266-023-01086-6","type":"journal-article","created":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T15:23:23Z","timestamp":1704209003000},"page":"77-78","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comment on: \u201cPatient Perceptions of Opioids and Benzodiazepines and Attitudes Toward Deprescribing\u201d"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0509-5136","authenticated-orcid":false,"given":"Aili V.","family":"Langford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl R.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Reeve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason N.","family":"Doctor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danijela","family":"Gnjidic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"1086_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s40266-023-01071-z","author":"CJ Kelley","year":"2023","unstructured":"Kelley CJ, Niznik JD, Ferreri SP, Schlusser C, Armistead LT, Hughes TD, Henage CB, Busby-Whitehead J, Roberts E. Patient perceptions of opioids and benzodiazepines and attitudes toward deprescribing. Drugs Aging. 2023. https:\/\/doi.org\/10.1007\/s40266-023-01071-z. (Epub ahead of print).","journal-title":"Drugs Aging"},{"issue":"11","key":"1086_CR2","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1097\/j.pain.0000000000002270","volume":"162","author":"AV Langford","year":"2021","unstructured":"Langford AV, Gnjidic D, Lin CC, Bero L, Blyth F, Penm J, Schneider CR. \u201cThe lesser of two evils\u201d: a framework analysis of consumers\u2019 perspectives on opioid deprescribing and the development of opioid deprescribing guidelines. Pain. 2021;162(11):2686\u201392. https:\/\/doi.org\/10.1097\/j.pain.0000000000002270.","journal-title":"Pain"},{"issue":"2","key":"1086_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/bmjqs-2020-010881","volume":"30","author":"AV Langford","year":"2021","unstructured":"Langford AV, Gnjidic D, Lin CC, Bero L, Penm J, Blyth FM, Schneider CR. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis. BMJ Qual Saf. 2021;30(2):133\u201340. https:\/\/doi.org\/10.1136\/bmjqs-2020-010881.","journal-title":"BMJ Qual Saf"},{"issue":"39","key":"1086_CR4","doi-asserted-by":"publisher","first-page":"E1222","DOI":"10.1503\/cmaj.170628","volume":"189","author":"DN Juurlink","year":"2017","unstructured":"Juurlink DN. Rethinking \u201cdoing well\u201d on chronic opioid therapy. CMAJ. 2017;189(39):E1222\u20133. https:\/\/doi.org\/10.1503\/cmaj.170628.","journal-title":"CMAJ"},{"issue":"9","key":"1086_CR5","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1001\/jamainternmed.2023.2847","volume":"183","author":"MD Sullivan","year":"2023","unstructured":"Sullivan MD, Linder JA, Doctor JN. Centers for Disease Control and Prevention Guideline for Prescribing Opioids, 2022\u2014need for integrating dosing benchmarks with shared decision-making. JAMA Intern Med. 2023;183(9):899\u2013900. https:\/\/doi.org\/10.1001\/jamainternmed.2023.2847.","journal-title":"JAMA Intern Med"},{"issue":"2","key":"1086_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.5694\/mja2.52002","volume":"219","author":"AV Langford","year":"2023","unstructured":"Langford AV, Lin CC, Bero L, Blyth FM, Doctor J, Holliday S, Jeon YH, Moullin J, Murnion B, Nielsen S, Osman R, Penm J, Reeve E, Reid S, Wale J, Schneider CR, Gnjidic D. Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations. Med J Aust. 2023;219(2):80\u20139. https:\/\/doi.org\/10.5694\/mja2.52002.","journal-title":"Med J Aust"},{"key":"1086_CR7","doi-asserted-by":"crossref","unstructured":"Langford AV, Schneider CR, Lin CC, Bero L, Blyth FM, Doctor J, Holliday S, Jeon YH, Moullin J, Murnion B, Nielsen S, Osman R, Penm J, Reeve E, Reid S, Wale J, Gnjidic D. Evidence-based clinical practice guideline for deprescribing opioid analgesics. The University of Sydney: Sydney. 2022. https:\/\/www.opioiddeprescribingguideline.com\/guideline. Accessed 16 Oct 2023","DOI":"10.5694\/mja2.52002"},{"issue":"1","key":"1086_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s13063-022-06164-5","volume":"23","author":"J Niznik","year":"2022","unstructured":"Niznik J, Ferreri SP, Armistead L, Urick B, Vest MH, Zhao L, Hughes T, McBride JM, Busby-Whitehead J. A deprescribing medication program to evaluate falls in older adults: methods for a randomized pragmatic clinical trial. Trials. 2022;23(1):256. https:\/\/doi.org\/10.1186\/s13063-022-06164-5.","journal-title":"Trials"},{"issue":"8","key":"1086_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161248","volume":"11","author":"B Farrell","year":"2016","unstructured":"Farrell B, Pottie K, Rojas-Fernandez CH, Bjerre LM, Thompson W, Welch V. Methodology for developing deprescribing guidelines: using evidence and GRADE to guide recommendations for deprescribing. PLoS ONE. 2016;11(8): e0161248. https:\/\/doi.org\/10.1371\/journal.pone.0161248.","journal-title":"PLoS ONE"},{"issue":"5","key":"1086_CR10","first-page":"339","volume":"64","author":"K Pottie","year":"2018","unstructured":"Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, Holbrook A, Boyd C, Swenson R, Ma A, Farrell B. Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline. Can Fam Physician. 2018;64(5):339\u201351.","journal-title":"Can Fam Physician"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01086-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-023-01086-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-023-01086-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T07:17:22Z","timestamp":1704525442000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-023-01086-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1086"],"URL":"https:\/\/doi.org\/10.1007\/s40266-023-01086-6","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"type":"print","value":"1170-229X"},{"type":"electronic","value":"1179-1969"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"20 November 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr E Reeve is funded by a National Health and Medical Research Council (NHMRC) Investigator Grant (1195460). Associate Professor D Gnjidic is supported by The University of Sydney Thompson Fellowship. The funding sources were not involved in study design; in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the article for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Dr Reeve receives royalties from UpToDate (Wolters Kluwer) for writing a chapter on deprescribing.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"AVL, CRS and DG conceived the letter and wrote the first draft of the manuscript. ER and JD critically revised subsequent drafts for important intellectual content. All authors approved the manuscript and agree to be accountable for its content.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors contributions"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent (participation & publication)"}},{"value":"Data sharing is not applicable to this article, as no datasets were generated or analysed during the current study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}